CAMP — CAMP4 Therapeutics Balance Sheet
0.000.00%
- $59.07m
- $20.10m
- $0.65m
- 19
- 18
- 32
- 11
Annual balance sheet for CAMP4 Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|
| Period Length: | — | — | — |
| Source: | PROSPECTUS | PROSPECTUS | 10-K |
| Standards: | USG | USG | USG |
| Status: | Final | Final | Final |
| Cash and Equivalents | |||
| Cash and Short Term Investments | 83.2 | 38.4 | 64 |
| Net Total Receivables | 0.84 | 0.922 | 1.09 |
| Prepaid Expenses | |||
| Total Other Current Assets | |||
| Total Current Assets | 84.4 | 40 | 66.4 |
| Gross Property, Plant And Equipment | |||
| Accumulated Depreciation | |||
| Net Property, Plant And Equipment | 16.8 | 13.3 | 10.3 |
| Other Long Term Assets | |||
| Total Assets | 103 | 54.9 | 78.3 |
| Accounts Payable | |||
| Accrued Expenses | |||
| Notes Payable / Short Term Debt | |||
| Current Portion of Long Term Debt / Capital Leases | |||
| Total Other Current Liabilities | |||
| Total Current Liabilities | 7.95 | 7.81 | 9.6 |
| Long Term Debt | |||
| Capital Lease Obligations | |||
| Total Long Term Debt | |||
| Total Debt | |||
| Total Other Liabilities | |||
| Total Liabilities | 17.9 | 16.5 | 15.2 |
| Redeemable Preferred Stock | |||
| Non Redeemable Preferred Stock | |||
| Common Stock | |||
| Additional Paid In Capital | |||
| Retained Earnings (Accumulated Deficit) | |||
| Other Equity | |||
| Total Equity | 84.6 | 38.4 | 63.1 |
| Total Liabilities & Shareholders' Equity | 103 | 54.9 | 78.3 |
| Total Common Shares Outstanding |